Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cullinan Therapeutics Inc (CGEM)

Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,054,126
  • Shares Outstanding, K 57,634
  • Annual Sales, $ 0 K
  • Annual Income, $ -153,160 K
  • 60-Month Beta -0.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade CGEM with:

Options Overview Details

View History
  • Implied Volatility 53.63% ( -47.84%)
  • Historical Volatility 78.92%
  • IV Percentile 2%
  • IV Rank 6.47%
  • IV High 206.00% on 09/15/23
  • IV Low 43.10% on 10/19/23
  • Put/Call Vol Ratio 2.00
  • Today's Volume 3
  • Volume Avg (30-Day) 311
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 6,496
  • Open Int (30-Day) 4,175

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.73
  • Number of Estimates 7
  • High Estimate -0.62
  • Low Estimate -0.89
  • Prior Year -0.82
  • Growth Rate Est. (year over year) +10.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.57 +21.58%
on 06/26/24
19.38 -2.32%
on 07/18/24
+1.50 (+8.61%)
since 06/21/24
3-Month
15.44 +22.60%
on 04/23/24
30.19 -37.29%
on 05/07/24
+3.30 (+21.11%)
since 04/22/24
52-Week
7.64 +147.77%
on 12/12/23
30.19 -37.29%
on 05/07/24
+8.46 (+80.80%)
since 07/21/23

Most Recent Stories

More News
REZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations

/PRNewswire/ -- Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Oncology, Inc., announced today the launch of the REZILIENT3 trial...

CGEM : 19.09 (+4.37%)
Why Shares of Cullinan Oncology Jumped This Week

The company's presentation at a conference got the attention of analysts and investors.

CGEM : 19.09 (+4.37%)
Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Completed agreement for strategic collaboration to jointly develop and commercialize CLN-081 with Taiho Pharmaceutical Presented updated Phase 1/2a data...

CGEM : 19.09 (+4.37%)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...

CGEM : 19.09 (+4.37%)
Cullinan Oncology to Participate in William Blair Biotech Focus Conference

CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a biopharmaceutical company focused on developing...

CGEM : 19.09 (+4.37%)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...

CGEM : 19.09 (+4.37%)
Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417

Cullinan Oncology receives upfront cash payment of $275 million, with potential to receive up to an additional $130 million in regulatory-based milestone...

CGEM : 19.09 (+4.37%)
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that the compensation committee...

CGEM : 19.09 (+4.37%)
Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting

Meeting to highlight updated data from the Phase 1/2a study of CLN-081 CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc....

CGEM : 19.09 (+4.37%)
Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference

CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a biopharmaceutical company focused on developing...

CGEM : 19.09 (+4.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Cullinan Therapeutics Inc. is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. The company's product pipeline consists CLN-978. Cullinan Therapeutics Inc., formerly known as Cullinan Oncology Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 19.01
2nd Resistance Point 18.76
1st Resistance Point 18.53
Last Price 19.09
1st Support Level 18.05
2nd Support Level 17.80
3rd Support Level 17.57

See More

52-Week High 30.19
Fibonacci 61.8% 21.58
Last Price 19.09
Fibonacci 50% 18.91
Fibonacci 38.2% 16.25
52-Week Low 7.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar